Pharmaceutical Industry Information Portal

HomeNews

News

Nuvaxovid is the first protein-based COVID-19 vaccine authorized in UK

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products...

New investments in the innovative biotechnology company “Target Medicals”

RDIF, AstraZeneca and Unicorn Capital Partners invest in Target Medicals, developing aldosterone synthase inhibitor for the treatment of resistant arterial hypertension. The Russian Direct Investment...

Rosselkhoznadzor removed the veterinary drug “Telazol 100 mg” from the list of prohibited

Rosselkhoznadzor announced that a veterinary drug Telazol 100 mg has been allowed to be imported into Russia. The decision comes after Rosselkhoznadzor has confirmed the...

Moderna’s Covid-19 vaccine SPIKEVAX receives full FDA approval

Moderna, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to...

Russia’s Petrovax ready to produce inhalable version of the Convidecia coronavirus vaccine

The launch of the project for the production of the inhalable version of the vaccine will depend on the registration of the injectable form...

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for...
spot_img

Expert Articles

spot_img